341 related articles for article (PubMed ID: 15986142)
1. Rb/E2F: a two-edged sword in the melanocytic system.
Halaban R
Cancer Metastasis Rev; 2005 Jun; 24(2):339-56. PubMed ID: 15986142
[TBL] [Abstract][Full Text] [Related]
2. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
Halaban R; Cheng E; Zhang Y; Mandigo CE; Miglarese MR
Oncogene; 1998 May; 16(19):2489-501. PubMed ID: 9627115
[TBL] [Abstract][Full Text] [Related]
3. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action.
Markey MP; Angus SP; Strobeck MW; Williams SL; Gunawardena RW; Aronow BJ; Knudsen ES
Cancer Res; 2002 Nov; 62(22):6587-97. PubMed ID: 12438254
[TBL] [Abstract][Full Text] [Related]
4. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
Gewirtz DA; Di YM; Randolph JK; Jain PT; Valerie K; Bullock S; Nath N; Chellappan SP
Arch Biochem Biophys; 2001 Apr; 388(2):243-52. PubMed ID: 11368161
[TBL] [Abstract][Full Text] [Related]
5. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of apoptotic genes by Rb in human versus mouse cells.
Young AP; Longmore GD
Oncogene; 2004 Apr; 23(15):2587-99. PubMed ID: 15048095
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
Tomari K; Kumagai T; Shimizu T; Takeda K
Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
[TBL] [Abstract][Full Text] [Related]
8. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway.
McCabe MT; Davis JN; Day ML
Cancer Res; 2005 May; 65(9):3624-32. PubMed ID: 15867357
[TBL] [Abstract][Full Text] [Related]
9. Abnormal cell cycle regulation in primary human uveal melanoma cultures.
Pardo M; Piñeiro A; de la Fuente M; García A; Prabhakar S; Zitzmann N; Dwek RA; Sánchez-Salorio M; Domínguez F; Capeans C
J Cell Biochem; 2004 Nov; 93(4):708-20. PubMed ID: 15660415
[TBL] [Abstract][Full Text] [Related]
10. The Rb/chromatin connection and epigenetic control: opinion.
Ferreira R; Naguibneva I; Pritchard LL; Ait-Si-Ali S; Harel-Bellan A
Oncogene; 2001 May; 20(24):3128-33. PubMed ID: 11420729
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes.
Bandyopadhyay D; Okan NA; Bales E; Nascimento L; Cole PA; Medrano EE
Cancer Res; 2002 Nov; 62(21):6231-9. PubMed ID: 12414652
[TBL] [Abstract][Full Text] [Related]
12. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
[TBL] [Abstract][Full Text] [Related]
13. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
Yamada M; Kondo T; Ashizawa S; Takebayashi T; Higashi H; Hatakeyama M
Cytokine; 2002 Jan; 17(2):91-7. PubMed ID: 11886176
[TBL] [Abstract][Full Text] [Related]
14. Activity of E2F-dependent promoters in bladder carcinoma cells and their use for tumour-specific targeting of p53-induced apoptosis.
Steinhoff C; Prior A; Reichmann G; Seifert HH; Schulz WA
Int J Oncol; 2002 Nov; 21(5):1033-40. PubMed ID: 12370752
[TBL] [Abstract][Full Text] [Related]
15. RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells.
Jori FP; Melone MA; Napolitano MA; Cipollaro M; Cascino A; Giordano A; Galderisi U
Cell Death Differ; 2005 Jan; 12(1):65-77. PubMed ID: 15459751
[TBL] [Abstract][Full Text] [Related]
16. IKK/NF-kappaB signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors.
Araki K; Kawauchi K; Tanaka N
Oncogene; 2008 Sep; 27(43):5696-705. PubMed ID: 18542057
[TBL] [Abstract][Full Text] [Related]
17. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
Zhou J; Ma J; Zhang BC; Li XL; Shen SR; Zhu SG; Xiong W; Liu HY; Huang H; Zhou M; Li GY
J Cell Physiol; 2004 Jul; 200(1):89-98. PubMed ID: 15137061
[TBL] [Abstract][Full Text] [Related]
18. Engineered mutants of pRB with improved growth suppression potential.
Antelman D; Perry S; Hollingsworth R; Gregory RJ; Driscoll B; Fung YK; Bookstein R
Oncogene; 1997 Dec; 15(23):2855-66. PubMed ID: 9419977
[TBL] [Abstract][Full Text] [Related]
19. Melanoma cell autonomous growth: the Rb/E2F pathway.
Halaban R
Cancer Metastasis Rev; 1999; 18(3):333-43. PubMed ID: 10721488
[TBL] [Abstract][Full Text] [Related]
20. The tyrphostin AG1024 accelerates the degradation of phosphorylated forms of retinoblastoma protein (pRb) and restores pRb tumor suppressive function in melanoma cells.
von Willebrand M; Zacksenhaus E; Cheng E; Glazer P; Halaban R
Cancer Res; 2003 Mar; 63(6):1420-9. PubMed ID: 12649208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
